ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,918,413 | +80541.4% | 140,039 | -7.3% | 0.19% | -13.5% |
| Q2 2023 | $3,619 | -9.2% | 151,107 | -28.6% | 0.22% | -12.2% |
| Q1 2023 | $3,986 | +20.0% | 211,777 | +1.5% | 0.24% | +19.5% |
| Q4 2022 | $3,323 | -99.9% | 208,749 | +4.4% | 0.20% | -4.7% |
| Q3 2022 | $3,273,000 | +17.4% | 200,032 | +1.1% | 0.22% | +24.3% |
| Q2 2022 | $2,789,000 | -45.5% | 197,915 | -6.4% | 0.17% | -36.4% |
| Q1 2022 | $5,122,000 | +15.4% | 211,492 | +11.2% | 0.27% | +24.8% |
| Q4 2021 | $4,438,000 | +47.2% | 190,155 | +4.8% | 0.22% | +38.0% |
| Q3 2021 | $3,014,000 | -26.5% | 181,463 | +8.0% | 0.16% | -27.9% |
| Q2 2021 | $4,100,000 | -0.1% | 168,099 | +5.6% | 0.22% | -11.3% |
| Q1 2021 | $4,105,000 | – | 159,124 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |